Literature DB >> 15294317

Rapid detection of ethambutol-resistant Mycobacterium tuberculosis strains by PCR-RFLP targeting embB codons 306 and 497 and iniA codon 501 mutations.

S Ahmad1, E Mokaddas, A-A Jaber.   

Abstract

Mutations at embB gene codons 306 and 497 and iniA gene codon 501 occur frequently in ethambutol (EMB)-resistant Mycobacterium tuberculosis strains worldwide. The identification of these mutations in resistant strains has been achieved by labor-intensive DNA sequencing or by tedious amplification protocols followed by restriction endonuclease digestion. In this report, we describe PCR-restriction fragment length polymorphism (RFLP)-based methods for determining substitutions at embB codons 306 and 497 and iniA codon 501 directly in BACTEC cultures of M. tuberculosis isolates. The wild-type and mutant alleles are revealed by easily interpretable and different RFLP patterns. The methods optimized initially on reference strains were tested directly on BACTEC cultures of 25 randomly selected clinical M. tuberculosis isolates, seven of which were determined to contain EMB-resistant strains by phenotypic drug susceptibility testing. The PCR-RFLP methods identified mutations in four of seven EMB-resistant strains with three isolates containing mutated embB codon 306 and one isolate containing mutated embB codon 497. The results of PCR-RFLP were confirmed by DNA sequencing. The worldwide prevalence figures for mutations at embB codons 306 and 497 and iniA codon 501 suggest that nearly half of EMB-resistant M. tuberculosis strains could be identified within one working day even in developing countries equipped with simple PCR technology instead of weeks required for phenotypic drug susceptibility testing. Further, since EMB resistance is also associated with multiple-drug resistance from some geographical locations, detection of EMB resistance may also lead to rapid identification of multidrug-resistant strains of M. tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15294317     DOI: 10.1016/j.mcp.2004.04.001

Source DB:  PubMed          Journal:  Mol Cell Probes        ISSN: 0890-8508            Impact factor:   2.365


  15 in total

Review 1.  Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other Mycobacteria.

Authors:  Tomasz Jagielski; Alina Minias; Jakko van Ingen; Nalin Rastogi; Anna Brzostek; Anna Żaczek; Jarosław Dziadek
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

2.  Performance Assessment of the Polymerase Chain Reaction-Restriction Fragment Length Polymorphism Method for Rapid Detection of Susceptibility to Ethambutol and Molecular Prediction of Extensively Drug-resistant Tuberculosis in Clinical Isolates of Mycobacterium tuberculosis.

Authors:  M Arjomandzadegan; R Nazari; M R Zolfaghari; M Taherahmadi; M Sadrnia; L P Titov; A Ahmadi; M Shojapoor
Journal:  West Indian Med J       Date:  2015-06-12       Impact factor: 0.171

3.  Comparative evaluation of INNO-LiPA HBV assay, direct DNA sequencing and subtractive PCR-RFLP for genotyping of clinical HBV isolates.

Authors:  Maisa M Ali; Fuad Hasan; Suhail Ahmad; Widad Al-Nakib
Journal:  Virol J       Date:  2010-05-30       Impact factor: 4.099

4.  Diagnosis of endocarditis caused by Mycobacterium abscessus.

Authors:  Khalifa Al-Benwan; Suhail Ahmad; Eiman Mokaddas; Molly Johny; Madan M Kapoor
Journal:  Ann Saudi Med       Date:  2010 Sep-Oct       Impact factor: 1.526

5.  Drug resistant strains of Mycobacterium tuberculosis identified through PCR-RFLP from patients of Central Punjab, Pakistan.

Authors:  Muhammad Riaz; Zahed Mahmood; Muhammad Tariq Javed; Irum Javed; Muhammad Shahid; Mazhar Abbas; Syed Ehtisham-Ul-Haque
Journal:  Int J Immunopathol Pharmacol       Date:  2016-04-11       Impact factor: 3.219

6.  Species spectrum of nontuberculous mycobacteria isolated from clinical specimens in Kuwait.

Authors:  Eiman Mokaddas; Suhail Ahmad
Journal:  Curr Microbiol       Date:  2008-01-30       Impact factor: 2.188

7.  Mutations at embB codon 306 are an important molecular indicator of ethambutol resistance in Mycobacterium tuberculosis.

Authors:  Angela M Starks; Aysel Gumusboga; Bonnie B Plikaytis; Thomas M Shinnick; James E Posey
Journal:  Antimicrob Agents Chemother       Date:  2008-12-22       Impact factor: 5.191

8.  Sequence analysis for detection of first-line drug resistance in Mycobacterium tuberculosis strains from a high-incidence setting.

Authors:  Silke Feuerriegel; Barbara Oberhauser; Abu Garawani George; Foday Dafae; Elvira Richter; Sabine Rüsch-Gerdes; Stefan Niemann
Journal:  BMC Microbiol       Date:  2012-05-30       Impact factor: 3.605

9.  Variations in the occurrence of specific rpoB mutations in rifampicin-resistant Mycobacterium tuberculosis isolates from patients of different ethnic groups in Kuwait.

Authors:  Suhail Ahmad; Noura M Al-Mutairi; Eiman Mokaddas
Journal:  Indian J Med Res       Date:  2012-05       Impact factor: 2.375

10.  First report of molecular detection of fluoroquinolone resistance-associated gyrA mutations in multidrug-resistant clinical Mycobacterium tuberculosis isolates in Kuwait.

Authors:  Noura M Al-Mutairi; Suhail Ahmad; Eiman Mokaddas
Journal:  BMC Res Notes       Date:  2011-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.